WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam, India joint venture, Granules OmniChem Priva

VANCOUVER, Aug. 29, 2019 /PRNewswire/ - Geyser Brands Inc. (TSXV:GYSR) ("Geyser Brands" or the "Company") today released its Q1 financial statements for the three months ended June 30, 2019. Interim financials and accompanying MD&A have been filed on SEDAR. The Company also updated this week that it is submitting all informatio

NEW YORK, Aug. 29, 2019 /PRNewswire/ -- Inc. magazine today revealed that Legwork is No. 1169 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy's most dynamic segment—its independent small businesses.

CRANFORD, N.J., Aug. 29, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will be presenting at the 4th annual Disruptive Growth Conference on Wednesday, September 4th at

LOVELAND, Colo., Aug. 29, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty healthcare products, today announced the realignment of its executive officers and the promotion in connection therewith of Nancy Wisnewski, Ph.D., from Executive V

SAN DIEGO, Aug. 29, 2019 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late‐stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Daniel P. Gold, Ph.D., president and chief executive officer, will present at the 2019 Wells Fargo Global Healthcare Conference on

HOUSTON, Aug. 29, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it is planning a proof of concept (POC) clinical

LAVAL, Quebec, Aug. 29, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in three investor conferences.Paul S. Herendeen, executive vice president and chief financial officer, Sam Eldessouky, senior vice president and corporate cont

InMed's Eric Hsu and Michael Woudenberg among Event's Expert Speakers VANCOUVER, Aug. 29, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technolog

MINNEAPOLIS, Aug. 29, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company with operations in 10 states and the Commonwealth of Puerto Rico, today reported financial results for its second quarter ended